PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011 Nov. (CADTH Optimal Use Report, No. 1.2A.)

APPENDIX 1EXPERT COMMITTEE AND CONTRIBUTORS

COMPUS Expert Review Committee (CERC) Members

Participating CERC Members

Dr. Lisa Dolovich, Chair, Research Director and Associate Professor, Department of Family Medicine, McMaster University, Ambulatory Care Pharmacotherapy Specialist, St. Joseph’s Healthcare Hamilton, Associate Director, Centre for Evaluation of Medicines

Members

Dr. Michael Allen, Associate Professor, Director, Evidence-based Programs, Continuing Medical Education, Dalhousie University

Dr. Michael Evans, Director, Patient Self-Management and Knowledge Support, Centre for Effective Practice, Department of Family and Community Medicine, University of Toronto

Dr. Scott Klarenbach, Associate Professor, Department of Medicine, Division of Nephrology, University of Alberta, Fellow, Institute of Health Economics

Ms. Cathy MacNutt, Public Member

Mr. Panos Petrides, Public Member

Dr. Jim Silvius, Senior Medical Director, Seniors’ Health, Alberta Health Services, Associate Professor, Division of Geriatric Medicine, Department of Medicine, University of Calgary

Dr. Adil Virani, Director, Pharmacy Services, Fraser Health Authority, Associate Professor, Faculty of Pharmaceutical Sciences, University of British Columbia

Specialist Members

Dr. Marc Carrier, Associate Scientist, Clinical Epidemiology, Ottawa Hospital Research Institute, Physician, Hematology (Thrombosis), The Ottawa Hospital, Assistant Professor, Department of Medicine, University of Ottawa

Dr. Agnes Y. Lee, Associate Professor of Medicine, Division of Hematology, University of British Columbia, Medical Director, Thrombosis Program, Vancouver Coastal Health, Diamond Health Care Centre

Dr. Jafna Cox, Heart and Stroke Foundation Endowed Chair in Cardiovascular Outcomes, Director of Research, Division of Cardiology Professor, Departments of Medicine and of Community Health and Epidemiology, Dalhousie University, Staff Cardiologist, Capital Health

Dr. Anne Holbrook, Professor and Director, Division of Clinical Pharmacology and Therapeutics, Department of Medicine, McMaster University, Senior Scientist, Centre for Evaluation of Medicines, Staff Physician, St. Joseph's Healthcare Hamilton, Staff Physician, Hamilton Health Sciences

Dr. Mario Talajic, Cardiac electrophysiologist, Director, Cardiac Genetics Centre, Montreal Heart Institute, JC Edwards Professor of Medicine, Director, Specialty Training Programs, Department of Medicine, University of Montreal

Dr. Leslie Zypchen — designated backup for Dr. Agnes Lee (sharing votes), Clinical Assistant Professor, Division of Hematology, University of British Columbia, Staff Hematologist, Vancouver General Hospital

Contributors from Canadian Agency for Drugs and Technologies in Health (CADTH)

Mr. Chris Kamel, Clinical Research Officer

Ms. Agnieszka Kus, Clinical Research Assistant

Ms. Heidi Staples, Clinical Research Officer

Ms. Kasia Kaluzny, Knowledge Exchange Officer

Dr. Mohammed Jabr, Health Economist

Mr. Michel Boucher, Theme Lead, Cardiovascular and Cerebrovascular

Dr. Chander Sehgal, Director, Formulary Reviews, Acting Director, Optimal Use and Health Technology Assessment

Ms. Gaetanne Murphy, Clinical Research Officer

Ms. Kelly Farrah, Information Specialist

Dr. Janice Mann, Knowledge Exchange Officer

Ms. Andra Morrison, Environmental Scanning Officer

Dr. Vijay Shukla, Senior Advisor, Advancing the Science

Dr. Srabani Banerjee, Manager, Clinical Research

Mr. Denis Belanger, Director, Impact, Partnership and Outreach

Conflict of Interest

No members declared any conflicts of interest. Conflict of Interest Guidelines are posted on the CADTH website.

Copyright © 2011 CADTH.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Cover of Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence
Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence [Internet].
CADTH Optimal Use Report, No. 1.2A.

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...